Unknown PHASE3 INTERVENTIONAL 2-arm NCT00645723

Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii

Phase 3b Randomized Double Blind Controled Placebo Comparative Trial of Intravenous Colistin vs Intravenous Colistin Plus Nebulized Colistin in Patients With Ventilator-associated Pneumonia (VAP) Due Multiresistant Acinetobacter Baumanii

Sponsor: Hospitales Universitarios Virgen del Rocío

Conditions Cross Infection Pneumonia, Bacterial

Interventions Colistin Colistin and saline solution

Updated 5 times since 2017 Last updated: Aug 3, 2009 Started: Apr 30, 2008 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cross Infection and Pneumonia, Bacterial and is currently ongoing. Hospitales Universitarios Virgen del Rocío leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Apr 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospitales Universitarios Virgen del Rocío

Data source: Hospitales Universitarios Virgen del Rocío

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seville, Spain